{"task_id": "a9f121d1fd7141f6", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 206/464)", "text": "112)\nGastric Cancer (p. 197)\nEsophageal Cancer\n195\n\n--- Page 217 ---\nSTAGING\nTNM STAGING\nT stage\n\u0002 T1=invades lamina propria or submucosa\n\u0002 T2=invades muscularis propria\n\u0002 T3=invades adventitia\n\u0002 T4=invades into adjacent structures (trachea,\nmediastinum)\nN stage (cervical paraesophageal, right recurrent\nlaryngeal, left paratracheal, upper and lower para\nesophageal, infraaortic, infracarinal and lower pos\nterior mediastinal regions)\n\u0002 N1=regional LN\nM stage (spreads rapidly and early. Over 50%\nunresectable/metastatic disease at presentation)\n\u0002 M1a=cervical (proximal esophagus) or celiac\n(distal esophagus) LN metastasis\n\u0002 M1b=distant metastasis\nSTAGE GROUPINGS\nStage\nTNM @=any\n5 year\nsurvival\n0\nTisN0M0\n>95%\nI\nT1N0M0\n50 80%\nIIA\nT2 3N0M0T\n30 40%\nIIB\nT1 2N1M0\n10 30%\nIII\nT3N1M0 T4N0 1M0\n10 15%\nIVA\nT@N@M1a\n<5%\nIVB\nT@N@M1b\n<1%\nINVESTIGATIONS\nBASIC\n\u0002\nLABS\nCBCD, lytes, urea, Cr, AST, ALT, ALP, bilir\nubin, INR, PTT, albumin, lipase, CEA\n\u0002\nIMAGING\nCXR, barium swallow, CT chest and\nabd, endoscopic U/S (excellent for staging), PET\nscan (preoperative workup)\n\u0002\nBIOPSY\ngastroscopy \u0006 laparoscopy\nDIAGNOSTIC AND PROGNOSTIC ISSUES\nSCREENING (for Barrett\u2019s)\nendoscopy with biopsy\nevery 3 5 year, yearly if low grade dysplasia\nPOOR PROGNOSTIC FACTORS\nweight loss >10%,\ndysphagia, large tumors, advanced age, lymphatic\nmicrometastases\nMANAGEMENT\nNUTRITIONAL SUPPORT\ndietician consult. Con\nsider supplemental feeding if significant weight\nloss, but only if benefits greater than risk\nRESECTABLE (T1 2, N0, 20%)\nsurgical resection\n(right transthoracic approach, transhiatal approach).\nDefinitive\nchemoradiation\n(5 fluorouracil\nplus\ncisplatin, 5000 cGy) may be a reasonable alternative\nto surgery, particularly for older individuals, medically\ninoperable patients, and cervical esophageal carci\nnoma (difficult resection). Neoadjuvant chemother\napy (ECF\u00033 (E=epirubicin, C=cisplatin, F=infusional\n5 fluorouracil)) + surgical resection followed by\nECF\u00033 similar to treatment for gastric cancer if GE\njunction involved, good performance status, and not\ndysphagic. Immediate resection followed by post\noperative chemoradiation if unsuitable for preo\nperative therapy\nLOCALLY ADVANCED, UNRESECTABLE (T3 4, N1,\n65%, median survival 12 14 months)\n\u0002\nADENOCARCINOMA\nprimary\nchemoradiation\nif\nlocalized. See also metastatic, unresectable cancer\n\u0002\nSQUAMOUS\nCELL\nCARCINOMA\nchemoradiation\n(5 fluorouracil plus cisplatin, 5000 cGy). Palliative\nsurgical resection may be considered for selected\npatients (increased local control), although squa\nmous cell carcinomas are very sensitive to che\nmoradiation, and thus surgery may not be\nneeded\nMETASTATIC, UNRESECTABLE (M1, 15%, median\nsurvival 9 12 months)\n\u0002\nPALLIATIVE CHEMOTHERAPY\nsimilar to gastric can\ncer. Standard regimens include ECF, DCF (D=doc\netaxel, C=cisplatin, F=5 fluorouracil), ECX and\nEOX, EOF (X=capecitabine, O=oxaliplatin). For\npatients with poor performance status, consider\nCF,\nFOLFIRI\n(5 fluorouracil leucovorin irinote\ncan), or 5 fluorouracil or irinotecan alone. No\nstandard for second line, which may include FOL\nFIRI, irinotecan alone, or taxane alone. Response\nrate 10 30% for single agents and 30 50% for\ncombination therapy\n\u0002\nPALLIATIVE\nRADIATION\nbrachytherapy,\nexternal\nbeam radiation\n\u0002\nPALLIATIVE PROCEDURES\ndilatation and endolum\ninal stent if obstruction, phototherapy, G tube\ninsertion\nTREATMENT ISSUES\nFOLLOW UP\nno agreed upon surveillance pro\ngram. Clinical assessment every 3 months during\nthe first year, then every 6 months for a total of 5\nyears. Endoscopy at 6 months, 18 months, then every\n2 3 years may be considered\nMANAGEMENT (CONT\u2019D)\n196\nEsophageal Cancer", "text_length": 3624, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 206/464)", "type": "chunk", "chunk_index": 205, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.529187", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.530391", "status": "complete", "chunks_added": 2}